Reacta Biotech Limited

Active08553682 Private limited company
Incorporated
3 June 2013 (13 years)
Industry
Research and experimental development on biotechnology (72110)
Directors
Richard Nagle
Robert Granville Barker
Owned by
Jon Moulton
Accounts type
Full
Region
Wales
Address
Unit 2 Newtech Square
Deeside Industrial Park
Deeside
CH5 2NT

Filing status

Accounts due
30 September 2027
Last accounts
31 December 2025
Conf. stmt due
23 June 2027
Last conf. stmt
9 June 2026

Charges

Total
3
Outstanding
1
Part satisfied
0
Satisfied
2

Officers 8 active

Officer details are public data from the Companies House register.

Nagle, Richard
Director · Appointed 10 March 2026
British
Born October 1966 (60)
Director · Appointed 15 April 2025
British
Born June 1974 (52)
Barker, Robert Granville
Director · Appointed 20 December 2023
British
Born April 1981 (45)
Bruce, Andrew Nicholas
Secretary · Appointed 23 October 2023
Thelwall-Jones, Simon
Director · Appointed 16 October 2023
British
Born August 1968 (58)
Wickham, Martin Sean John, Dr
Director · Appointed 10 February 2022
British
Born April 1971 (55)
Abrahams, Paul Andrew, Dr
Director · Appointed 20 November 2018
British
Born January 1971 (55)
Director · Appointed 3 June 2013
British
Born April 1951 (75)
Officer history (7 former)
10 March 2026
Appointed Nagle, Richard as Director
24 June 2025
Resigned Weaver, Christopher Guy as Director
15 April 2025
Appointed Field, Adrian Ivery as Director
15 April 2025
Appointed Weaver, Christopher Guy as Director
20 December 2023
Appointed Barker, Robert Granville as Director
23 October 2023
Appointed Bruce, Andrew Nicholas as Secretary
16 October 2023
Appointed Thelwall-Jones, Simon as Director
17 January 2023
Resigned Sumner, Andrew Neil as Director
21 October 2022
Resigned Molyneux, Norman as Director
10 February 2022
Appointed Wickham, Martin Sean John, Dr as Director
8 July 2021
Appointed Sumner, Andrew Neil as Director
1 December 2019
Resigned Lambert, Elizabeth Naomi Clare, Dr as Director
29 March 2019
Resigned Rogers, David as Director
20 November 2018
Appointed Abrahams, Paul Andrew, Dr as Director
22 February 2017
Resigned Mcpartland, Peter as Director
27 October 2016
Resigned Haumann, Brett Kenneth, Dr as Director
29 April 2016
Appointed Rogers, David as Director
18 June 2014
Appointed Haumann, Brett Kenneth, Dr as Director
29 May 2014
Appointed Molyneux, Norman as Director
3 June 2013
3 June 2013
Appointed Mcpartland, Peter as Director
3 June 2013
Appointed Lambert, Elizabeth Naomi Clare, Dr as Director

Ownership 2 active

People and entities with significant control, from the Companies House PSC register

Corporate entity · Notified 27 July 2023
Owns 25–50% of shares
Holds 25–50% of voting rights
Limited Company
Reg. no. 05210122
Jon Moulton
Individual · Notified 1 June 2018
Owns 25–50% of shares
Holds 25–50% of voting rights
British
Born October 1950 (76)

Holdings 1

Companies where Reacta Biotech Limited is registered as a person with significant control

Owns 75–100% of shares
Active
Former controllers (3)
21 January 2020
Ceased Ashley Arthur Woodcock — Has significant influence or control
1 December 2019
Ceased Elizabeth Naomi Clare Mills — Has significant influence or control
1 June 2018
Ceased Moulton Goodies Ltd — Owns 25–50% of shares

Group structure 42 shown

Ownership group derived from the Companies House PSC register

DBW Holdings Limited Owns 75–100% of shares
DBW Investments (10) Limited Owns 75–100% of shares
DBW Investments (11) Limited Owns 75–100% of shares
DBW Investments (12) Limited Owns 75–100% of shares
DBW Investments (14) Limited Owns 75–100% of shares
Salus Healthcare Group Limited Owns 25–50% of shares
DBW Investments (2) Limited Owns 75–100% of shares
DBW Investments (3) Limited Owns 75–100% of shares
Electra Nest Ltd Holds 50–75% of voting rights
Reacta Biotech Limited This company Owns 25–50% of shares
Tourhub Ltd Owns 25–50% of shares
DBW Investments (4) Limited Owns 75–100% of shares
DBW Investments (5) Limited Owns 75–100% of shares
DBW Investments (6) Limited Owns 75–100% of shares
DBW Investments (8) Limited Owns 75–100% of shares
DBW Investments (9) Limited Owns 75–100% of shares
DBW Investments (Mims) Limited Owns 75–100% of shares
Help to Buy (Wales) Limited Owns 75–100% of shares
DBW Managers Limited Owns 75–100% of shares
DBW FM Limited Owns 75–100% of shares
Laser Wire Solutions Limited Owns 25–50% of shares
FW Capital Limited Owns 75–100% of shares
FWC Cip Limited Owns 75–100% of shares
FWC Ifw Debt GP Limited Owns 75–100% of shares
FWC Loans (North West) Limited Owns 75–100% of shares
FWC Loans (TVC) Limited Owns 75–100% of shares
FWC NE Debt GP Limited Owns 75–100% of shares
FWC Npifii Debt GP Limited Owns 75–100% of shares
FWC Swif Debt GP Limited Owns 75–100% of shares
FWC Sypa Debt GP Limited Owns 75–100% of shares
Management Succession GP Limited Owns 75–100% of shares
KW Group (2022) Ltd Owns 25–50% of shares
NE Commercial Property (GP) Limited Owns 75–100% of shares
North East Property (GP) Limited Owns 75–100% of shares
North West Loans Npif GP Limited Owns 75–100% of shares
TVC Loans Npif GP Limited Owns 75–100% of shares
DBW Services Limited Owns 75–100% of shares
Angels Invest Wales Limited Has significant influence or control
Economic Intelligence Wales Limited Owns 75–100% of shares
Net Zero Industry Wales Limited Holds 75–100% of voting rights
FWC Tfif GP Limited Owns 75–100% of shares

Financials

Net Assets
£1,989,814
Cash
£861,038
Employees
43
Debt Ratio
40%
Current Ratio
2.3x

Trend

Net Assets
(£2.0M) £0 £2.0M 2019 2020 2021 2022 2023 (£580,075) (£62,187) £1,216,964 £424,913 £1,989,814
Balance sheet detail
20232022202120202019
Fixed Assets£746,515£707,883£122,451£81,268£90,421
Current Assets£2,558,946£1,025,765£2,643,253£536,084£178,922
Debtors£1,316,506£348,914£443,283£286,463£129,614
Cash£861,038£624,034£2,185,640£233,880£13,647
Creditors (< 1 year)£1,119,836£1,268,927£1,498,940£618,574£618,669
Creditors (> 1 year)£195,811£39,808£49,800£60,965£230,749
Net Current Assets£1,439,110(£243,162)£1,144,313(£82,490)(£439,747)
Net Assets£1,989,814£424,913£1,216,964(£62,187)(£580,075)
Shareholder Funds£424,913£1,216,964(£62,187)(£580,075)

Filings

Recent filings only. See the full history on Companies House

DateDescriptionMade Up ToPagesPDF
21 August 2026Statement of capital following an allotment of shares

Other companies in this industry

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?